Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
出版年份 2020 全文链接
标题
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-04-08
DOI
10.3389/fimmu.2020.00635
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release
- (2019) Shaimaa Mahmoud et al. Cells
- Immunological Aspects of Approved MS Therapeutics
- (2019) Paulus S. Rommer et al. Frontiers in Immunology
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Differentiation of Sendai virus-reprogrammed iPSC into β cells, compared with human pancreatic islets and immortalized β cell line
- (2018) Silvia Pellegrini et al. CELL TRANSPLANTATION
- Astroglial glutamate transporters in the brain: Regulating neurotransmitter homeostasis and synaptic transmission
- (2017) Ciaran Murphy-Royal et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Fingolimod effects in neuroinflammation: Regulation of astroglial glutamate transporters?
- (2017) De-Hyung Lee et al. PLoS One
- Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
- (2017) Alberto Gajofatto Drug Design Development and Therapy
- Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model
- (2016) T. Draheim et al. GLIA
- Cell Line Macroarray
- (2016) Alberto La Spada et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
- (2016) Antonietta Gentile et al. Journal of Neuroinflammation
- The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
- (2016) Catherine O’Sullivan et al. Journal of Neuroinflammation
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
- (2016) Richard Macrez et al. LANCET NEUROLOGY
- FTY720 attenuates excitotoxicity and neuroinflammation
- (2015) Raffaela Cipriani et al. Journal of Neuroinflammation
- FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
- (2015) Felix Luessi et al. Multiple Sclerosis Journal
- FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis
- (2015) Felix Luessi et al. Multiple Sclerosis Journal
- Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
- (2014) Emanuela Colombo et al. ANNALS OF NEUROLOGY
- Astrogliosis
- (2014) Michael V. Sofroniew Cold Spring Harbor Perspectives in Biology
- Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes
- (2013) Xu Wang et al. ACTA NEUROPATHOLOGICA
- Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes
- (2013) Luke M Healy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fingolimod phosphate promotes the neuroprotective effects of microglia
- (2013) Hiromi Noda et al. JOURNAL OF NEUROIMMUNOLOGY
- Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
- (2013) Celina Wu et al. Journal of Neuroinflammation
- Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
- (2013) Aran Groves et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Reactive Oxygen Species from Human Astrocytes Induced Functional Impairment and Oxidative Damage
- (2013) Wen S. Sheng et al. NEUROCHEMICAL RESEARCH
- Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
- (2013) Peter Reinhardt et al. PLoS One
- Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS
- (2013) K. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
- (2012) P Gergely et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis
- (2012) Jean Quancard et al. CHEMISTRY & BIOLOGY
- Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration
- (2012) Emanuela Colombo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
- (2011) B. Soliven et al. NEUROLOGY
- Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions
- (2011) Iris Fischer et al. PLoS One
- Blood sphingolipidomics in healthy humans: impact of sample collection methodology
- (2010) Samar M. Hammad et al. JOURNAL OF LIPID RESEARCH
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
- (2010) J. W. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Nrf2–ARE cytoprotective pathway in astrocytes
- (2009) Marcelo R. Vargas et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Transgenic Inhibition of Astroglial NF- B Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation
- (2009) R. Brambilla et al. JOURNAL OF IMMUNOLOGY
- Transgenic inhibition of astroglial NF-κB leads to increased axonal sparing and sprouting following spinal cord injury
- (2009) Roberta Brambilla et al. JOURNAL OF NEUROCHEMISTRY
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
- (2009) Florian Mullershausen et al. Nature Chemical Biology
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started